Evidence map›Paper›PMID 40183557›Full record

ArticleJournal of bacteriology2025

Kiera Englehart, Jonathan Dworkin

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Analysis of essential genes inJournal of bacteriology · 2025
    Article
  4. Analysis of Essential Genes inbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kiera EnglehartDepartment of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Jonathan DworkinDepartment of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.ORCID 0000-0002-8205-6918

Funding

Regulation of quiescence in bacteriaR35GM141953 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jonathan Dworkin · 2021 to 2026
$2.5M
NIGMS NIH HHS R35 GM141953
6 · The paper itself

Abstract

Identification of the protein that mediates transbilayer transport of the undecaprenyl-pyrophosphate (Und-PP) linked peptidoglycan precursor Lipid II has long been a subject of investigation. Candidates belonging to both the MOP (multidrug/oligosaccharidyl-lipid/polysaccharide) and SEDS (shape, elongation, division and sporulation) families of transmembrane proteins have been proposed, exhibiting characteristics consistent with mediating this process, including genetic essentiality and biochemical activity. While MOP family proteins including MurJ are widely considered to be the primary Lipid II transporter, questions still remain including a role for the SEDS proteins in this process. We and others previously showed that a

Indexed as

Bacillus subtilisBacterial ProteinsPhospholipid Transfer ProteinsUridine Diphosphate N-Acetylmuramic AcidGene Expression Regulation, BacterialBacterial Proteinsmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolPhospholipid Transfer ProteinsUridine Diphosphate N-Acetylmuramic Acidpeptidoglycan

Identifiers

PMID40183557
PMCPMC12096821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.